Fiona Dunlevy
Directeur/Membre du Conseil chez MALIN CORPORATION PLC
Postes actifs de Fiona Dunlevy
Sociétés | Poste | Début | Fin |
---|---|---|---|
MALIN CORPORATION PLC | Secrétaire Général | 18/09/2018 | - |
Directeur/Membre du Conseil | 27/10/2023 | - | |
Comptroller/Controller/Auditor | 01/01/2015 | 18/09/2018 | |
Wavebreak Therapeutics Ltd.
Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Wavebreak Therapeutics Ltd. operates as a biopharmaceutical company that focuses on drug discovery and subsequent clinical translation of molecules which will impact protein misfolding diseases. Its proprietary technology platform is built on new and fundamental understanding of the origins of these diseases and is based on decades of scientific research at the University of Cambridge and Lund University. The company was founded by Christopher Dobson, Michele Vendruscolo, and Tuomas Knowles on March 10, 2016 and is headquartered in Cambridge, the United Kingdom. | Directeur/Membre du Conseil | 29/11/2018 | - |
Irish Taxation Institute
Irish Taxation Institute Miscellaneous Commercial ServicesCommercial Services Irish Taxation Institute provides tax education to the businesses, multinationals and individuals. The company was founded on November 10, 1967 and is headquartered in Dublin, Ireland. | Corporate Officer/Principal | - | - |
Chartered Accountants Ireland | Corporate Officer/Principal | - | - |
Historique de carrière de Fiona Dunlevy
Statistiques
Internationale
Irlande | 4 |
Royaume-Uni | 2 |
Opérationnelle
Director/Board Member | 2 |
Corporate Officer/Principal | 2 |
Comptroller/Controller/Auditor | 1 |
Sectorielle
Health Technology | 3 |
Commercial Services | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
MALIN CORPORATION PLC | Health Technology |
Entreprise privées | 2 |
---|---|
Wavebreak Therapeutics Ltd.
Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Wavebreak Therapeutics Ltd. operates as a biopharmaceutical company that focuses on drug discovery and subsequent clinical translation of molecules which will impact protein misfolding diseases. Its proprietary technology platform is built on new and fundamental understanding of the origins of these diseases and is based on decades of scientific research at the University of Cambridge and Lund University. The company was founded by Christopher Dobson, Michele Vendruscolo, and Tuomas Knowles on March 10, 2016 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Irish Taxation Institute
Irish Taxation Institute Miscellaneous Commercial ServicesCommercial Services Irish Taxation Institute provides tax education to the businesses, multinationals and individuals. The company was founded on November 10, 1967 and is headquartered in Dublin, Ireland. | Commercial Services |
- Bourse
- Insiders
- Fiona Dunlevy
- Expérience